PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum
2026-08-19T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion
2026-08-19T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NORROY BIOSCIENCE Granted FDA Breakthrough Therapy and Fast Track Designations for Kidney Cancer Imaging Product
2026-08-19T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Strong growth from Vyepti® and focused commercial execution drive total revenue growth of +16% CER (+13% CER underlying) in H1 2026
2026-08-19T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Everest Medicines Announces Interim Results for First Half of 2026
2026-08-19T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma
2026-08-19T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit
2026-08-19T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
CARsgen Therapeutics Announces 2026 Interim Results
2026-08-19T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
2026-08-19T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
2026-08-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.